

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA unwinding involved in DNA replication (GO:0006268) | 6.16485510 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.77879430 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.77879430 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.77599935 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.77599935 |
| 6 | establishment of integrated proviral latency (GO:0075713) | 5.69105804 |
| 7 | DNA strand elongation involved in DNA replication (GO:0006271) | 5.46832975 |
| 8 | DNA strand elongation (GO:0022616) | 5.29857225 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 5.16594231 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.96829790 |
| 11 | protein maturation by protein folding (GO:0022417) | 4.89778217 |
| 12 | negative regulation of fibrinolysis (GO:0051918) | 4.84548302 |
| 13 | kynurenine metabolic process (GO:0070189) | 4.84521533 |
| 14 | glycine metabolic process (GO:0006544) | 4.75112876 |
| 15 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.74347367 |
| 16 | protein carboxylation (GO:0018214) | 4.72408663 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.72408663 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 4.66686904 |
| 19 | tryptophan catabolic process (GO:0006569) | 4.66686904 |
| 20 | indole-containing compound catabolic process (GO:0042436) | 4.66686904 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 4.63795222 |
| 22 | glyoxylate metabolic process (GO:0046487) | 4.60814997 |
| 23 | establishment of viral latency (GO:0019043) | 4.55496334 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 4.54468446 |
| 25 | bile acid biosynthetic process (GO:0006699) | 4.51290564 |
| 26 | urea cycle (GO:0000050) | 4.46679781 |
| 27 | urea metabolic process (GO:0019627) | 4.46679781 |
| 28 | tryptophan metabolic process (GO:0006568) | 4.41902846 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 4.41056248 |
| 30 | regulation of fibrinolysis (GO:0051917) | 4.40138752 |
| 31 | regulation of protein activation cascade (GO:2000257) | 4.38082168 |
| 32 | mitotic chromosome condensation (GO:0007076) | 4.37079719 |
| 33 | DNA replication initiation (GO:0006270) | 4.29901710 |
| 34 | cysteine metabolic process (GO:0006534) | 4.25856203 |
| 35 | lysine catabolic process (GO:0006554) | 4.25538239 |
| 36 | lysine metabolic process (GO:0006553) | 4.25538239 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 4.25282923 |
| 38 | complement activation, alternative pathway (GO:0006957) | 4.16353963 |
| 39 | serine family amino acid biosynthetic process (GO:0009070) | 4.13300299 |
| 40 | regulation of complement activation (GO:0030449) | 4.12078610 |
| 41 | nitrogen cycle metabolic process (GO:0071941) | 4.07453050 |
| 42 | serine family amino acid metabolic process (GO:0009069) | 3.93311560 |
| 43 | negative regulation of cholesterol transport (GO:0032375) | 3.92894875 |
| 44 | negative regulation of sterol transport (GO:0032372) | 3.92894875 |
| 45 | imidazole-containing compound metabolic process (GO:0052803) | 3.92793928 |
| 46 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.90159270 |
| 47 | regulation of cholesterol esterification (GO:0010872) | 3.89748162 |
| 48 | IMP biosynthetic process (GO:0006188) | 3.88636680 |
| 49 | heterochromatin organization (GO:0070828) | 3.86415033 |
| 50 | homocysteine metabolic process (GO:0050667) | 3.86075371 |
| 51 | reverse cholesterol transport (GO:0043691) | 3.83922721 |
| 52 | bile acid metabolic process (GO:0008206) | 3.79583784 |
| 53 | IMP metabolic process (GO:0046040) | 3.78388776 |
| 54 | aromatic amino acid family metabolic process (GO:0009072) | 3.77451587 |
| 55 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.76891729 |
| 56 | triglyceride homeostasis (GO:0070328) | 3.75935055 |
| 57 | acylglycerol homeostasis (GO:0055090) | 3.75935055 |
| 58 | tetrahydrofolate metabolic process (GO:0046653) | 3.75913228 |
| 59 | telomere maintenance via recombination (GO:0000722) | 3.73650744 |
| 60 | protein-lipid complex remodeling (GO:0034368) | 3.72806587 |
| 61 | macromolecular complex remodeling (GO:0034367) | 3.72806587 |
| 62 | plasma lipoprotein particle remodeling (GO:0034369) | 3.72806587 |
| 63 | regulation of triglyceride catabolic process (GO:0010896) | 3.71635328 |
| 64 | amino-acid betaine metabolic process (GO:0006577) | 3.71445024 |
| 65 | alpha-amino acid catabolic process (GO:1901606) | 3.69712132 |
| 66 | plasma lipoprotein particle clearance (GO:0034381) | 3.68116213 |
| 67 | one-carbon metabolic process (GO:0006730) | 3.64308341 |
| 68 | phospholipid efflux (GO:0033700) | 3.62295723 |
| 69 | proline biosynthetic process (GO:0006561) | 3.61832638 |
| 70 | tyrosine metabolic process (GO:0006570) | 3.60062090 |
| 71 | regulation of cholesterol homeostasis (GO:2000188) | 3.59961750 |
| 72 | protein localization to chromosome, centromeric region (GO:0071459) | 3.57185035 |
| 73 | regulation of translational fidelity (GO:0006450) | 3.57030943 |
| 74 | ethanol oxidation (GO:0006069) | 3.55878918 |
| 75 | L-serine metabolic process (GO:0006563) | 3.55441257 |
| 76 | nuclear pore complex assembly (GO:0051292) | 3.54065142 |
| 77 | protein localization to kinetochore (GO:0034501) | 3.53555867 |
| 78 | mitotic sister chromatid segregation (GO:0000070) | 3.53287645 |
| 79 | mitotic recombination (GO:0006312) | 3.49789524 |
| 80 | mitotic nuclear envelope disassembly (GO:0007077) | 3.44571768 |
| 81 | fibrinolysis (GO:0042730) | 3.41335517 |
| 82 | folic acid metabolic process (GO:0046655) | 3.40187163 |
| 83 | cellular modified amino acid catabolic process (GO:0042219) | 3.37624756 |
| 84 | cellular amino acid catabolic process (GO:0009063) | 3.37501572 |
| 85 | DNA replication checkpoint (GO:0000076) | 3.36506859 |
| 86 | mitotic metaphase plate congression (GO:0007080) | 3.35714281 |
| 87 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.34695758 |
| 88 | formation of translation preinitiation complex (GO:0001731) | 3.34670690 |
| 89 | NADH metabolic process (GO:0006734) | 3.33914458 |
| 90 | protein complex localization (GO:0031503) | 3.32982793 |
| 91 | pentose-phosphate shunt (GO:0006098) | 3.32565020 |
| 92 | cellular glucuronidation (GO:0052695) | 3.32054278 |
| 93 | benzene-containing compound metabolic process (GO:0042537) | 3.31427796 |
| 94 | coenzyme catabolic process (GO:0009109) | 3.30940993 |
| 95 | bile acid and bile salt transport (GO:0015721) | 3.30902826 |
| 96 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.29782820 |
| 97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.29782820 |
| 98 | blood coagulation, intrinsic pathway (GO:0007597) | 3.29634480 |
| 99 | aldehyde catabolic process (GO:0046185) | 3.27232029 |
| 100 | 2-oxoglutarate metabolic process (GO:0006103) | 3.24263781 |
| 101 | plasma lipoprotein particle assembly (GO:0034377) | 3.24195521 |
| 102 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.23203687 |
| 103 | valine metabolic process (GO:0006573) | 3.19831998 |
| 104 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.19324025 |
| 105 | NADPH regeneration (GO:0006740) | 3.18890239 |
| 106 | indolalkylamine metabolic process (GO:0006586) | 3.18843877 |
| 107 | membrane disassembly (GO:0030397) | 3.15773289 |
| 108 | nuclear envelope disassembly (GO:0051081) | 3.15773289 |
| 109 | telomere maintenance via telomere lengthening (GO:0010833) | 3.14493348 |
| 110 | nucleobase biosynthetic process (GO:0046112) | 3.13763076 |
| 111 | base-excision repair (GO:0006284) | 3.12894706 |
| 112 | folic acid-containing compound metabolic process (GO:0006760) | 3.12590364 |
| 113 | cofactor catabolic process (GO:0051187) | 3.11939824 |
| 114 | epoxygenase P450 pathway (GO:0019373) | 3.11838722 |
| 115 | cholesterol efflux (GO:0033344) | 3.10638048 |
| 116 | sister chromatid segregation (GO:0000819) | 3.09227667 |
| 117 | purine nucleobase biosynthetic process (GO:0009113) | 3.09218377 |
| 118 | ribosome assembly (GO:0042255) | 3.08864617 |
| 119 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.07947671 |
| 120 | nuclear pore organization (GO:0006999) | 3.07564235 |
| 121 | histone arginine methylation (GO:0034969) | 3.06884254 |
| 122 | cholesterol homeostasis (GO:0042632) | 3.06434059 |
| 123 | 4-hydroxyproline metabolic process (GO:0019471) | 3.06326964 |
| 124 | arginine metabolic process (GO:0006525) | 3.05856815 |
| 125 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.04737925 |
| 126 | COPI coating of Golgi vesicle (GO:0048205) | 3.03478881 |
| 127 | Golgi transport vesicle coating (GO:0048200) | 3.03478881 |
| 128 | cellular biogenic amine catabolic process (GO:0042402) | 3.03180486 |
| 129 | amine catabolic process (GO:0009310) | 3.03180486 |
| 130 | regulation of plasminogen activation (GO:0010755) | 3.01179129 |
| 131 | glutamate metabolic process (GO:0006536) | 3.01092937 |
| 132 | regulation of mitochondrial translation (GO:0070129) | 3.00714601 |
| 133 | sterol homeostasis (GO:0055092) | 3.00043705 |
| 134 | mitotic nuclear envelope reassembly (GO:0007084) | 2.99963085 |
| 135 | nuclear envelope reassembly (GO:0031468) | 2.99963085 |
| 136 | cellular ketone body metabolic process (GO:0046950) | 2.99961403 |
| 137 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.99935374 |
| 138 | response to nitrosative stress (GO:0051409) | 2.99017133 |
| 139 | low-density lipoprotein particle remodeling (GO:0034374) | 2.97336934 |
| 140 | lipoprotein metabolic process (GO:0042157) | 2.97134836 |
| 141 | protein activation cascade (GO:0072376) | 2.96956292 |
| 142 | phospholipid homeostasis (GO:0055091) | 2.96569402 |
| 143 | acetyl-CoA metabolic process (GO:0006084) | 2.96063170 |
| 144 | protein-lipid complex assembly (GO:0065005) | 2.96052074 |
| 145 | glucose catabolic process (GO:0006007) | 2.95329429 |
| 146 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.94721287 |
| 147 | cellular protein complex localization (GO:0034629) | 2.94601157 |
| 148 | complement activation, classical pathway (GO:0006958) | 2.93618049 |
| 149 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.90513789 |
| 150 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.87818380 |
| 151 | tricarboxylic acid cycle (GO:0006099) | 2.87261690 |
| 152 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.85622168 |
| 153 | DNA duplex unwinding (GO:0032508) | 2.82202100 |
| 154 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.81611876 |
| 155 | regulation of spindle organization (GO:0090224) | 2.80792352 |
| 156 | chromosome condensation (GO:0030261) | 2.78623321 |
| 157 | glycolytic process (GO:0006096) | 2.76131818 |
| 158 | metaphase plate congression (GO:0051310) | 2.75428737 |
| 159 | positive regulation of chromosome segregation (GO:0051984) | 2.74961413 |
| 160 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.74861081 |
| 161 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.74571986 |
| 162 | regulation of mitotic spindle organization (GO:0060236) | 2.74098417 |
| 163 | proline metabolic process (GO:0006560) | 2.67982731 |
| 164 | pore complex assembly (GO:0046931) | 2.67219662 |
| 165 | gluconeogenesis (GO:0006094) | 2.66880252 |
| 166 | DNA geometric change (GO:0032392) | 2.66711840 |
| 167 | heme biosynthetic process (GO:0006783) | 2.65941625 |
| 168 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.63152392 |
| 169 | protein retention in ER lumen (GO:0006621) | 2.63063918 |
| 170 | tRNA aminoacylation for protein translation (GO:0006418) | 2.62929941 |
| 171 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.59929292 |
| 172 | monosaccharide biosynthetic process (GO:0046364) | 2.58868018 |
| 173 | oxaloacetate metabolic process (GO:0006107) | 2.58442141 |
| 174 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.57485176 |
| 175 | CENP-A containing nucleosome assembly (GO:0034080) | 2.56618971 |
| 176 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.55739757 |
| 177 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.55447817 |
| 178 | DNA conformation change (GO:0071103) | 2.54947093 |
| 179 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.54582875 |
| 180 | nuclear envelope organization (GO:0006998) | 2.54024756 |
| 181 | peptidyl-arginine methylation (GO:0018216) | 2.53523118 |
| 182 | peptidyl-arginine N-methylation (GO:0035246) | 2.53523118 |
| 183 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.53521102 |
| 184 | hexose biosynthetic process (GO:0019319) | 2.52676228 |
| 185 | oxidative phosphorylation (GO:0006119) | 2.51124178 |
| 186 | ribosome biogenesis (GO:0042254) | 2.51021542 |
| 187 | amino acid activation (GO:0043038) | 2.50528866 |
| 188 | tRNA aminoacylation (GO:0043039) | 2.50528866 |
| 189 | proteasome assembly (GO:0043248) | 2.49921386 |
| 190 | negative regulation of chromosome segregation (GO:0051985) | 2.49646680 |
| 191 | DNA topological change (GO:0006265) | 2.48750604 |
| 192 | regulation of translational termination (GO:0006449) | 2.48254625 |
| 193 | chromatin remodeling at centromere (GO:0031055) | 2.47472196 |
| 194 | regulation of chromosome segregation (GO:0051983) | 2.47049097 |
| 195 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.46828007 |
| 196 | negative regulation of ligase activity (GO:0051352) | 2.45845758 |
| 197 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.45845758 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.18392926 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.89338160 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.80518316 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.48770714 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.79503288 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.75220094 |
| 7 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.56179556 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.38113246 |
| 9 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.09144210 |
| 10 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.96111018 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.69215735 |
| 12 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.62221968 |
| 13 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.60436787 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.29824747 |
| 15 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.28074619 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.12906819 |
| 17 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.98997548 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.91758510 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.87580872 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.84183902 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.78570974 |
| 22 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.74786442 |
| 23 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.72128280 |
| 24 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.71594994 |
| 25 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.66994478 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.64834208 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.63740481 |
| 28 | * MYC_22102868_ChIP-Seq_BL_Human | 1.58007109 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57898364 |
| 30 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.57638240 |
| 31 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.52113904 |
| 32 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.51680292 |
| 33 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.47003585 |
| 34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.46984074 |
| 35 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.46736131 |
| 36 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.46161139 |
| 37 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.46156428 |
| 38 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.44973864 |
| 39 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.44374091 |
| 40 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.42776413 |
| 41 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41090254 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.41067076 |
| 43 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.40396559 |
| 44 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.40174536 |
| 45 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.38715771 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.37448558 |
| 47 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.34837981 |
| 48 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.33313737 |
| 49 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.28733611 |
| 50 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.25162525 |
| 51 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.23584731 |
| 52 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.22350829 |
| 53 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21147007 |
| 54 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.20291749 |
| 55 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17818749 |
| 56 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.17630976 |
| 57 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.17604313 |
| 58 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.14147246 |
| 59 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.12112828 |
| 60 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10990675 |
| 61 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10723965 |
| 62 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.08380702 |
| 63 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.08209981 |
| 64 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.06499897 |
| 65 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.05479138 |
| 66 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.04885433 |
| 67 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.04801755 |
| 68 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.04752042 |
| 69 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.04502451 |
| 70 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.04142043 |
| 71 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04115845 |
| 72 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03690017 |
| 73 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03225949 |
| 74 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.03176162 |
| 75 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.02969868 |
| 76 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02663498 |
| 77 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02588384 |
| 78 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.01994075 |
| 79 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.01828292 |
| 80 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.00867229 |
| 81 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.99822329 |
| 82 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.99449312 |
| 83 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.99331878 |
| 84 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.98828807 |
| 85 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.98014901 |
| 86 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.97886872 |
| 87 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.97533617 |
| 88 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.96330508 |
| 89 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.93974348 |
| 90 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.93519776 |
| 91 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.93481437 |
| 92 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.93306528 |
| 93 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.92925018 |
| 94 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.91975324 |
| 95 | ATF3_27146783_Chip-Seq_COLON_Human | 0.91932178 |
| 96 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91792175 |
| 97 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.91672365 |
| 98 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.91131544 |
| 99 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.90783404 |
| 100 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.90488120 |
| 101 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.90222250 |
| 102 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.89648225 |
| 103 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.89276069 |
| 104 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88418477 |
| 105 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88061906 |
| 106 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.85808438 |
| 107 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.85780786 |
| 108 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.85256052 |
| 109 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.85200472 |
| 110 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85149084 |
| 111 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.84869804 |
| 112 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.83460306 |
| 113 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82753595 |
| 114 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81719408 |
| 115 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.81373074 |
| 116 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.81014648 |
| 117 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.80975176 |
| 118 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.80743548 |
| 119 | MAF_26560356_Chip-Seq_TH1_Human | 0.80465396 |
| 120 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.80391291 |
| 121 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.79412815 |
| 122 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.79021964 |
| 123 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78699466 |
| 124 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.77762349 |
| 125 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.76937726 |
| 126 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.76620222 |
| 127 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76614009 |
| 128 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.75861390 |
| 129 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.75841950 |
| 130 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.75819297 |
| 131 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.75794074 |
| 132 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75048119 |
| 133 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.74411159 |
| 134 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74356229 |
| 135 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74224059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.15042104 |
| 2 | MP0005360_urolithiasis | 5.87198733 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.69037546 |
| 4 | MP0005365_abnormal_bile_salt | 4.47252683 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 4.44405255 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.49112798 |
| 7 | MP0009840_abnormal_foam_cell | 3.22053309 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 3.01452347 |
| 9 | MP0003252_abnormal_bile_duct | 2.91056755 |
| 10 | MP0000751_myopathy | 2.87432779 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.66462725 |
| 12 | MP0010030_abnormal_orbit_morphology | 2.59624797 |
| 13 | MP0005083_abnormal_biliary_tract | 2.47894492 |
| 14 | MP0008932_abnormal_embryonic_tissue | 2.46776855 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.36011280 |
| 16 | MP0003195_calcinosis | 2.34875879 |
| 17 | MP0008058_abnormal_DNA_repair | 2.23632802 |
| 18 | MP0004233_abnormal_muscle_weight | 2.13680883 |
| 19 | MP0000749_muscle_degeneration | 1.97694249 |
| 20 | MP0000609_abnormal_liver_physiology | 1.95709395 |
| 21 | MP0005332_abnormal_amino_acid | 1.95600268 |
| 22 | MP0008057_abnormal_DNA_replication | 1.82381389 |
| 23 | MP0004185_abnormal_adipocyte_glucose | 1.79428432 |
| 24 | MP0003718_maternal_effect | 1.75997731 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.70653514 |
| 26 | MP0001666_abnormal_nutrient_absorption | 1.66851040 |
| 27 | MP0001661_extended_life_span | 1.65907302 |
| 28 | MP0008438_abnormal_cutaneous_collagen | 1.62146692 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 1.61525575 |
| 30 | MP0003123_paternal_imprinting | 1.60581301 |
| 31 | MP0000350_abnormal_cell_proliferation | 1.60169405 |
| 32 | MP0004147_increased_porphyrin_level | 1.59235857 |
| 33 | MP0005380_embryogenesis_phenotype | 1.54689140 |
| 34 | MP0001672_abnormal_embryogenesis/_devel | 1.54689140 |
| 35 | MP0003984_embryonic_growth_retardation | 1.52123607 |
| 36 | MP0002080_prenatal_lethality | 1.51264006 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.49251316 |
| 38 | MP0004087_abnormal_muscle_fiber | 1.49002180 |
| 39 | MP0000747_muscle_weakness | 1.48253982 |
| 40 | MP0002118_abnormal_lipid_homeostasis | 1.47244430 |
| 41 | MP0003950_abnormal_plasma_membrane | 1.47117907 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.43189759 |
| 43 | MP0003941_abnormal_skin_development | 1.43188296 |
| 44 | MP0002088_abnormal_embryonic_growth/wei | 1.41839571 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.41553247 |
| 46 | MP0002796_impaired_skin_barrier | 1.40965736 |
| 47 | MP0003186_abnormal_redox_activity | 1.40885368 |
| 48 | MP0005257_abnormal_intraocular_pressure | 1.35481136 |
| 49 | MP0000750_abnormal_muscle_regeneration | 1.34767513 |
| 50 | MP0001764_abnormal_homeostasis | 1.33959624 |
| 51 | MP0004019_abnormal_vitamin_homeostasis | 1.33612621 |
| 52 | MP0010630_abnormal_cardiac_muscle | 1.32201405 |
| 53 | MP0001697_abnormal_embryo_size | 1.31851823 |
| 54 | MP0004084_abnormal_cardiac_muscle | 1.31735860 |
| 55 | MP0003786_premature_aging | 1.29351119 |
| 56 | MP0000598_abnormal_liver_morphology | 1.29231658 |
| 57 | MP0000003_abnormal_adipose_tissue | 1.25049979 |
| 58 | MP0005375_adipose_tissue_phenotype | 1.22057267 |
| 59 | MP0001849_ear_inflammation | 1.20990572 |
| 60 | MP0002106_abnormal_muscle_physiology | 1.18468524 |
| 61 | MP0000759_abnormal_skeletal_muscle | 1.16418902 |
| 62 | MP0006138_congestive_heart_failure | 1.16415633 |
| 63 | MP0010352_gastrointestinal_tract_polyps | 1.16332595 |
| 64 | MP0004036_abnormal_muscle_relaxation | 1.16195738 |
| 65 | MP0009643_abnormal_urine_homeostasis | 1.15820160 |
| 66 | MP0005023_abnormal_wound_healing | 1.14724310 |
| 67 | MP0002085_abnormal_embryonic_tissue | 1.14519154 |
| 68 | MP0006054_spinal_hemorrhage | 1.13761154 |
| 69 | MP0005501_abnormal_skin_physiology | 1.13013400 |
| 70 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.12397860 |
| 71 | MP0000313_abnormal_cell_death | 1.09386412 |
| 72 | MP0009763_increased_sensitivity_to | 1.08122033 |
| 73 | MP0002254_reproductive_system_inflammat | 1.07348371 |
| 74 | MP0006035_abnormal_mitochondrial_morpho | 1.05717583 |
| 75 | MP0005670_abnormal_white_adipose | 1.02918270 |
| 76 | MP0008260_abnormal_autophagy | 1.01015672 |
| 77 | MP0003868_abnormal_feces_composition | 0.99507888 |
| 78 | MP0005369_muscle_phenotype | 0.97653088 |
| 79 | MP0003693_abnormal_embryo_hatching | 0.95182587 |
| 80 | MP0003724_increased_susceptibility_to | 0.94851087 |
| 81 | MP0004145_abnormal_muscle_electrophysio | 0.93098520 |
| 82 | MP0001243_abnormal_dermal_layer | 0.92312192 |
| 83 | MP0003566_abnormal_cell_adhesion | 0.92269243 |
| 84 | MP0001853_heart_inflammation | 0.91350405 |
| 85 | MP0003279_aneurysm | 0.90909158 |
| 86 | MP0005275_abnormal_skin_tensile | 0.90190819 |
| 87 | MP0003300_gastrointestinal_ulcer | 0.90123506 |
| 88 | MP0002084_abnormal_developmental_patter | 0.89010015 |
| 89 | MP0008469_abnormal_protein_level | 0.89006602 |
| 90 | MP0005165_increased_susceptibility_to | 0.88368909 |
| 91 | MP0002972_abnormal_cardiac_muscle | 0.88294985 |
| 92 | MP0006036_abnormal_mitochondrial_physio | 0.88160951 |
| 93 | MP0003315_abnormal_perineum_morphology | 0.87764268 |
| 94 | MP0000358_abnormal_cell_content/ | 0.87425919 |
| 95 | MP0003436_decreased_susceptibility_to | 0.86855018 |
| 96 | MP0003567_abnormal_fetal_cardiomyocyte | 0.85540870 |
| 97 | MP0005266_abnormal_metabolism | 0.85400381 |
| 98 | MP0004957_abnormal_blastocyst_morpholog | 0.85220225 |
| 99 | MP0008775_abnormal_heart_ventricle | 0.85114538 |
| 100 | MP0009703_decreased_birth_body | 0.82441918 |
| 101 | MP0003221_abnormal_cardiomyocyte_apopto | 0.81579542 |
| 102 | MP0002060_abnormal_skin_morphology | 0.81522566 |
| 103 | MP0005376_homeostasis/metabolism_phenot | 0.79925413 |
| 104 | MP0005397_hematopoietic_system_phenotyp | 0.79090558 |
| 105 | MP0001545_abnormal_hematopoietic_system | 0.79090558 |
| 106 | MP0002396_abnormal_hematopoietic_system | 0.79016236 |
| 107 | MP0002877_abnormal_melanocyte_morpholog | 0.78560227 |
| 108 | MP0009764_decreased_sensitivity_to | 0.77842648 |
| 109 | MP0001727_abnormal_embryo_implantation | 0.75692873 |
| 110 | MP0005636_abnormal_mineral_homeostasis | 0.74827522 |
| 111 | MP0005384_cellular_phenotype | 0.73716037 |
| 112 | MP0005621_abnormal_cell_physiology | 0.73674571 |
| 113 | MP0003111_abnormal_nucleus_morphology | 0.72207903 |
| 114 | MP0005220_abnormal_exocrine_pancreas | 0.72166346 |
| 115 | MP0010094_abnormal_chromosome_stability | 0.71468888 |
| 116 | MP0009642_abnormal_blood_homeostasis | 0.70854396 |
| 117 | MP0000678_abnormal_parathyroid_gland | 0.70107504 |
| 118 | MP0005647_abnormal_sex_gland | 0.69640334 |
| 119 | MP0005464_abnormal_platelet_physiology | 0.69466233 |
| 120 | MP0002269_muscular_atrophy | 0.69253330 |
| 121 | MP0000266_abnormal_heart_morphology | 0.68108856 |
| 122 | MP0001915_intracranial_hemorrhage | 0.66872486 |
| 123 | MP0009697_abnormal_copulation | 0.66761446 |
| 124 | MP0000858_altered_metastatic_potential | 0.65893794 |
| 125 | MP0010307_abnormal_tumor_latency | 0.65882687 |
| 126 | MP0002697_abnormal_eye_size | 0.65460832 |
| 127 | MP0001542_abnormal_bone_strength | 0.64609059 |
| 128 | MP0000537_abnormal_urethra_morphology | 0.64365642 |
| 129 | MP0000685_abnormal_immune_system | 0.62806392 |
| 130 | MP0003077_abnormal_cell_cycle | 0.60625025 |
| 131 | MP0003011_delayed_dark_adaptation | 0.60202882 |
| 132 | MP0002970_abnormal_white_adipose | 0.59962895 |
| 133 | MP0005503_abnormal_tendon_morphology | 0.59396652 |
| 134 | MP0009765_abnormal_xenobiotic_induced | 0.57920868 |
| 135 | MP0002078_abnormal_glucose_homeostasis | 0.57346671 |
| 136 | MP0005408_hypopigmentation | 0.57214902 |
| 137 | MP0001730_embryonic_growth_arrest | 0.56727934 |
| 138 | MP0005451_abnormal_body_composition | 0.56278415 |
| 139 | MP0001533_abnormal_skeleton_physiology | 0.55596956 |
| 140 | MP0008007_abnormal_cellular_replicative | 0.55494957 |
| 141 | MP0004272_abnormal_basement_membrane | 0.55317499 |
| 142 | MP0009053_abnormal_anal_canal | 0.55083397 |
| 143 | MP0002019_abnormal_tumor_incidence | 0.54982840 |
| 144 | MP0005076_abnormal_cell_differentiation | 0.54882921 |
| 145 | MP0008873_increased_physiological_sensi | 0.54693513 |
| 146 | MP0005666_abnormal_adipose_tissue | 0.54672748 |
| 147 | MP0000604_amyloidosis | 0.54221501 |
| 148 | MP0001881_abnormal_mammary_gland | 0.53639247 |
| 149 | MP0009278_abnormal_bone_marrow | 0.53085273 |
| 150 | MP0004130_abnormal_muscle_cell | 0.52537272 |
| 151 | MP0001756_abnormal_urination | 0.52062151 |
| 152 | MP0002971_abnormal_brown_adipose | 0.52022151 |
| 153 | MP0002086_abnormal_extraembryonic_tissu | 0.51025429 |
| 154 | MP0000249_abnormal_blood_vessel | 0.50276565 |
| 155 | MP0005330_cardiomyopathy | 0.49776581 |
| 156 | MP0004947_skin_inflammation | 0.48576306 |
| 157 | MP0002933_joint_inflammation | 0.48366138 |
| 158 | MP0004197_abnormal_fetal_growth/weight/ | 0.48072547 |
| 159 | MP0002136_abnormal_kidney_physiology | 0.47876363 |
| 160 | MP0009672_abnormal_birth_weight | 0.47623669 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.09300263 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.92273341 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.76894539 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 5.73350845 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 5.13588661 |
| 6 | Xanthomatosis (HP:0000991) | 5.09948789 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.78526224 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.03315417 |
| 9 | Complement deficiency (HP:0004431) | 4.02146162 |
| 10 | Hypolipoproteinemia (HP:0010981) | 3.96722683 |
| 11 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.91186758 |
| 12 | Hypoglycemic coma (HP:0001325) | 3.81201200 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 3.77399065 |
| 14 | Hyperammonemia (HP:0001987) | 3.76059177 |
| 15 | Joint hemorrhage (HP:0005261) | 3.58224591 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 3.55437979 |
| 17 | Abnormality of the intrinsic pathway (HP:0010989) | 3.54117214 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.52226381 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.42377778 |
| 20 | Abnormality of glycolysis (HP:0004366) | 3.41204861 |
| 21 | Progressive muscle weakness (HP:0003323) | 3.38055492 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 3.33189198 |
| 23 | Ketosis (HP:0001946) | 3.32599273 |
| 24 | Abnormality of complement system (HP:0005339) | 3.32588358 |
| 25 | Epidermoid cyst (HP:0200040) | 3.27351071 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.17270313 |
| 27 | Hyperglycinemia (HP:0002154) | 3.07914000 |
| 28 | Hyperbilirubinemia (HP:0002904) | 3.06702754 |
| 29 | Fat malabsorption (HP:0002630) | 3.02648066 |
| 30 | Increased serum pyruvate (HP:0003542) | 3.02225258 |
| 31 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.99803100 |
| 32 | Hyperglycinuria (HP:0003108) | 2.91926903 |
| 33 | Hypercholesterolemia (HP:0003124) | 2.91060500 |
| 34 | Spastic diplegia (HP:0001264) | 2.90900673 |
| 35 | Distal lower limb muscle weakness (HP:0009053) | 2.87791734 |
| 36 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.87559142 |
| 37 | Exercise-induced muscle cramps (HP:0003710) | 2.83852314 |
| 38 | Myocardial infarction (HP:0001658) | 2.81977025 |
| 39 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.81075768 |
| 40 | Abnormality of glycine metabolism (HP:0010895) | 2.81075768 |
| 41 | Hepatocellular carcinoma (HP:0001402) | 2.79095583 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 2.73700666 |
| 43 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.71122537 |
| 44 | Microvesicular hepatic steatosis (HP:0001414) | 2.64835899 |
| 45 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.63277437 |
| 46 | Trismus (HP:0000211) | 2.62250517 |
| 47 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.60006186 |
| 48 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.59804207 |
| 49 | Ragged-red muscle fibers (HP:0003200) | 2.55835609 |
| 50 | Nemaline bodies (HP:0003798) | 2.55268381 |
| 51 | Protrusio acetabuli (HP:0003179) | 2.54226275 |
| 52 | Chromsome breakage (HP:0040012) | 2.51639832 |
| 53 | Abnormal cartilage morphology (HP:0002763) | 2.44745104 |
| 54 | Delayed CNS myelination (HP:0002188) | 2.43249034 |
| 55 | Nonimmune hydrops fetalis (HP:0001790) | 2.42666458 |
| 56 | Abnormality of iron homeostasis (HP:0011031) | 2.42520750 |
| 57 | Ketoacidosis (HP:0001993) | 2.42453840 |
| 58 | Cholelithiasis (HP:0001081) | 2.41870804 |
| 59 | Skin nodule (HP:0200036) | 2.41417581 |
| 60 | Abnormal gallbladder morphology (HP:0012437) | 2.38322821 |
| 61 | Myoglobinuria (HP:0002913) | 2.37496696 |
| 62 | Reticulocytosis (HP:0001923) | 2.33076975 |
| 63 | Steatorrhea (HP:0002570) | 2.29724063 |
| 64 | Rhabdomyolysis (HP:0003201) | 2.29657568 |
| 65 | Hypochromic microcytic anemia (HP:0004840) | 2.28577596 |
| 66 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.27743883 |
| 67 | Reduced antithrombin III activity (HP:0001976) | 2.27206758 |
| 68 | Myopathic facies (HP:0002058) | 2.26615208 |
| 69 | Exercise-induced myalgia (HP:0003738) | 2.26253144 |
| 70 | Abnormality of serum amino acid levels (HP:0003112) | 2.25795835 |
| 71 | Distal lower limb amyotrophy (HP:0008944) | 2.25666561 |
| 72 | Selective tooth agenesis (HP:0001592) | 2.24247841 |
| 73 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.24231241 |
| 74 | Birth length less than 3rd percentile (HP:0003561) | 2.24198554 |
| 75 | Poikilocytosis (HP:0004447) | 2.23540688 |
| 76 | Hypoglycemic seizures (HP:0002173) | 2.22532543 |
| 77 | Muscle fiber inclusion bodies (HP:0100299) | 2.19896390 |
| 78 | Mitral stenosis (HP:0001718) | 2.18517842 |
| 79 | Limb-girdle muscle atrophy (HP:0003797) | 2.17132812 |
| 80 | Esophageal varix (HP:0002040) | 2.16405918 |
| 81 | Increased serum ferritin (HP:0003281) | 2.15860270 |
| 82 | Muscle stiffness (HP:0003552) | 2.15652735 |
| 83 | Abnormality of purine metabolism (HP:0004352) | 2.14957620 |
| 84 | Testicular atrophy (HP:0000029) | 2.14580534 |
| 85 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.13203245 |
| 86 | Dicarboxylic aciduria (HP:0003215) | 2.13203245 |
| 87 | Systemic lupus erythematosus (HP:0002725) | 2.13041660 |
| 88 | Type I transferrin isoform profile (HP:0003642) | 2.12226990 |
| 89 | Reticulocytopenia (HP:0001896) | 2.12060078 |
| 90 | Late onset (HP:0003584) | 2.10919601 |
| 91 | Right ventricular cardiomyopathy (HP:0011663) | 2.08800083 |
| 92 | High pitched voice (HP:0001620) | 2.07971100 |
| 93 | Microglossia (HP:0000171) | 2.06516029 |
| 94 | Vertebral compression fractures (HP:0002953) | 2.06339031 |
| 95 | Conjugated hyperbilirubinemia (HP:0002908) | 2.05952692 |
| 96 | Vascular calcification (HP:0004934) | 2.05731183 |
| 97 | Secondary amenorrhea (HP:0000869) | 2.05658982 |
| 98 | Premature rupture of membranes (HP:0001788) | 2.05497235 |
| 99 | Increased mean platelet volume (HP:0011877) | 2.04527743 |
| 100 | Rough bone trabeculation (HP:0100670) | 2.03877582 |
| 101 | Cardiovascular calcification (HP:0011915) | 2.03788571 |
| 102 | Polycythemia (HP:0001901) | 2.00479842 |
| 103 | EMG: myopathic abnormalities (HP:0003458) | 1.99813291 |
| 104 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99733596 |
| 105 | Neonatal onset (HP:0003623) | 1.97777163 |
| 106 | Acanthocytosis (HP:0001927) | 1.97641748 |
| 107 | Metabolic acidosis (HP:0001942) | 1.97085372 |
| 108 | Abnormality of the Achilles tendon (HP:0005109) | 1.96268584 |
| 109 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.96149090 |
| 110 | Orthostatic hypotension (HP:0001278) | 1.93810628 |
| 111 | Abnormal gallbladder physiology (HP:0012438) | 1.93361515 |
| 112 | Cholecystitis (HP:0001082) | 1.93361515 |
| 113 | Thrombophlebitis (HP:0004418) | 1.92768858 |
| 114 | Progressive external ophthalmoplegia (HP:0000590) | 1.92643536 |
| 115 | Back pain (HP:0003418) | 1.91074832 |
| 116 | Skull defect (HP:0001362) | 1.88409335 |
| 117 | Shoulder girdle muscle weakness (HP:0003547) | 1.87972989 |
| 118 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.87866640 |
| 119 | Nausea (HP:0002018) | 1.86727818 |
| 120 | Difficulty climbing stairs (HP:0003551) | 1.85924693 |
| 121 | Abnormality of the gallbladder (HP:0005264) | 1.85837727 |
| 122 | Spontaneous abortion (HP:0005268) | 1.84657257 |
| 123 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.83917393 |
| 124 | Abnormal platelet volume (HP:0011876) | 1.83839951 |
| 125 | Lethargy (HP:0001254) | 1.83721188 |
| 126 | Exercise intolerance (HP:0003546) | 1.83058402 |
| 127 | Malnutrition (HP:0004395) | 1.81002576 |
| 128 | Hypokinesia (HP:0002375) | 1.80828681 |
| 129 | Ventricular tachycardia (HP:0004756) | 1.80787099 |
| 130 | Spinal rigidity (HP:0003306) | 1.80786918 |
| 131 | Opisthotonus (HP:0002179) | 1.80052586 |
| 132 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.79803646 |
| 133 | Generalized amyotrophy (HP:0003700) | 1.79796029 |
| 134 | Abnormal number of erythroid precursors (HP:0012131) | 1.79626616 |
| 135 | Menorrhagia (HP:0000132) | 1.79410543 |
| 136 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.79003348 |
| 137 | Glomerulonephritis (HP:0000099) | 1.78563504 |
| 138 | Breech presentation (HP:0001623) | 1.77112730 |
| 139 | Increased nuchal translucency (HP:0010880) | 1.77024792 |
| 140 | Generalized aminoaciduria (HP:0002909) | 1.76781207 |
| 141 | Neck muscle weakness (HP:0000467) | 1.74387347 |
| 142 | Abnormality of the umbilical cord (HP:0010881) | 1.74089868 |
| 143 | Gout (HP:0001997) | 1.73792881 |
| 144 | Hemorrhage of the eye (HP:0011885) | 1.73337292 |
| 145 | Insomnia (HP:0100785) | 1.73150420 |
| 146 | Gingival bleeding (HP:0000225) | 1.72093347 |
| 147 | Hypertriglyceridemia (HP:0002155) | 1.70954371 |
| 148 | Achilles tendon contracture (HP:0001771) | 1.69244463 |
| 149 | Paralysis (HP:0003470) | 1.69184655 |
| 150 | Multiple enchondromatosis (HP:0005701) | 1.69030924 |
| 151 | Diaphragmatic weakness (HP:0009113) | 1.68340577 |
| 152 | Peritonitis (HP:0002586) | 1.68044259 |
| 153 | Abnormality of reticulocytes (HP:0004312) | 1.67924832 |
| 154 | Increased variability in muscle fiber diameter (HP:0003557) | 1.67839218 |
| 155 | Insulin resistance (HP:0000855) | 1.67646072 |
| 156 | Irritability (HP:0000737) | 1.67184826 |
| 157 | Hyperglycemia (HP:0003074) | 1.66940982 |
| 158 | Upper limb muscle weakness (HP:0003484) | 1.65416320 |
| 159 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.65136176 |
| 160 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.64824474 |
| 161 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.64824474 |
| 162 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.64364964 |
| 163 | Pancreatitis (HP:0001733) | 1.63670978 |
| 164 | Increased connective tissue (HP:0009025) | 1.63573185 |
| 165 | Ependymoma (HP:0002888) | 1.62697885 |
| 166 | Deviation of the thumb (HP:0009603) | 1.61898345 |
| 167 | Proximal placement of thumb (HP:0009623) | 1.60214427 |
| 168 | Sudden death (HP:0001699) | 1.60209185 |
| 169 | Fasciculations (HP:0002380) | 1.59947936 |
| 170 | Lower limb amyotrophy (HP:0007210) | 1.59608499 |
| 171 | Palpitations (HP:0001962) | 1.59478675 |
| 172 | Cortical dysplasia (HP:0002539) | 1.57405355 |
| 173 | Dilated cardiomyopathy (HP:0001644) | 1.56446314 |
| 174 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.56130235 |
| 175 | Osteolytic defects of the hand bones (HP:0009699) | 1.56130235 |
| 176 | Lipoatrophy (HP:0100578) | 1.55412247 |
| 177 | Breast hypoplasia (HP:0003187) | 1.55240980 |
| 178 | Symptomatic seizures (HP:0011145) | 1.54417927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.77999452 |
| 2 | BCKDK | 3.90788571 |
| 3 | PKN2 | 3.76552930 |
| 4 | ERN1 | 3.65657638 |
| 5 | SMG1 | 3.59296235 |
| 6 | KDR | 3.21941483 |
| 7 | SIK1 | 3.21294241 |
| 8 | TRIB3 | 3.19535682 |
| 9 | FLT3 | 2.83083609 |
| 10 | FGFR4 | 2.64633237 |
| 11 | MAP3K10 | 2.27869230 |
| 12 | SRPK1 | 2.24310921 |
| 13 | NME2 | 2.08523212 |
| 14 | TAF1 | 1.98963803 |
| 15 | EEF2K | 1.98277812 |
| 16 | EPHA2 | 1.76700424 |
| 17 | ICK | 1.73729044 |
| 18 | TGFBR1 | 1.53571966 |
| 19 | CDC7 | 1.53182980 |
| 20 | WEE1 | 1.52953108 |
| 21 | MAP2K3 | 1.51962382 |
| 22 | NEK1 | 1.48582307 |
| 23 | TYK2 | 1.44904147 |
| 24 | DAPK1 | 1.44845946 |
| 25 | TTN | 1.42644054 |
| 26 | MAPKAPK3 | 1.40652618 |
| 27 | PTK6 | 1.39859232 |
| 28 | ARAF | 1.37780207 |
| 29 | PBK | 1.32860506 |
| 30 | LIMK1 | 1.31679127 |
| 31 | BUB1 | 1.30926179 |
| 32 | RPS6KB2 | 1.30165271 |
| 33 | VRK1 | 1.29229771 |
| 34 | TGFBR2 | 1.29143120 |
| 35 | MAP3K3 | 1.28660119 |
| 36 | PLK3 | 1.27740961 |
| 37 | CHEK2 | 1.27199511 |
| 38 | MAP4K1 | 1.26587831 |
| 39 | IRAK3 | 1.22493188 |
| 40 | NEK2 | 1.20975334 |
| 41 | CDK4 | 1.16791550 |
| 42 | NME1 | 1.16652913 |
| 43 | TESK2 | 1.16080337 |
| 44 | RPS6KA4 | 1.15238683 |
| 45 | MAPK11 | 1.13833180 |
| 46 | STK10 | 1.13700911 |
| 47 | PASK | 1.10879970 |
| 48 | EIF2AK1 | 1.09935688 |
| 49 | LRRK2 | 1.06957279 |
| 50 | PAK4 | 1.04539590 |
| 51 | ZAP70 | 1.00164407 |
| 52 | PRPF4B | 0.98997577 |
| 53 | STK16 | 0.98901271 |
| 54 | PIK3CG | 0.98687697 |
| 55 | SCYL2 | 0.98096240 |
| 56 | CDK6 | 0.98031643 |
| 57 | NEK9 | 0.97727139 |
| 58 | BRSK1 | 0.97653070 |
| 59 | PLK4 | 0.96691085 |
| 60 | LMTK2 | 0.94823359 |
| 61 | MAP3K8 | 0.94331644 |
| 62 | TIE1 | 0.94232559 |
| 63 | CDK7 | 0.93522155 |
| 64 | ACVR1B | 0.93322939 |
| 65 | CDK12 | 0.91861390 |
| 66 | TBK1 | 0.91305167 |
| 67 | PDGFRA | 0.90542528 |
| 68 | BRAF | 0.89487454 |
| 69 | MAP3K11 | 0.88735558 |
| 70 | JAK3 | 0.88511173 |
| 71 | TSSK6 | 0.87016987 |
| 72 | CHEK1 | 0.86973264 |
| 73 | CDK8 | 0.84377189 |
| 74 | JAK2 | 0.80022507 |
| 75 | MTOR | 0.77932479 |
| 76 | RIPK1 | 0.76935088 |
| 77 | STK4 | 0.76120961 |
| 78 | TTK | 0.75165523 |
| 79 | PIM2 | 0.75130278 |
| 80 | ERBB4 | 0.73371637 |
| 81 | DMPK | 0.72685134 |
| 82 | AURKB | 0.71427130 |
| 83 | MATK | 0.69935988 |
| 84 | PIM1 | 0.69825393 |
| 85 | CDK9 | 0.67800367 |
| 86 | ALK | 0.67486529 |
| 87 | JAK1 | 0.67183760 |
| 88 | MST4 | 0.67062415 |
| 89 | TAOK3 | 0.66447697 |
| 90 | GRK6 | 0.65848623 |
| 91 | TLK1 | 0.63112440 |
| 92 | DAPK3 | 0.61568894 |
| 93 | ABL2 | 0.59210095 |
| 94 | MET | 0.58804169 |
| 95 | CSF1R | 0.58684636 |
| 96 | PAK1 | 0.58654306 |
| 97 | CSK | 0.58588868 |
| 98 | PAK2 | 0.58370163 |
| 99 | ATM | 0.58281372 |
| 100 | BRSK2 | 0.57444482 |
| 101 | LATS1 | 0.56669145 |
| 102 | LATS2 | 0.55735989 |
| 103 | DYRK1B | 0.55042021 |
| 104 | EPHB1 | 0.55016327 |
| 105 | MAPKAPK5 | 0.54349115 |
| 106 | CDK1 | 0.53500664 |
| 107 | PHKG1 | 0.53157873 |
| 108 | PHKG2 | 0.53157873 |
| 109 | MKNK1 | 0.53088385 |
| 110 | ATR | 0.52902791 |
| 111 | INSRR | 0.52479871 |
| 112 | TAOK2 | 0.50991780 |
| 113 | PTK2 | 0.50736013 |
| 114 | MOS | 0.50228045 |
| 115 | PLK1 | 0.50213204 |
| 116 | CDK2 | 0.50088683 |
| 117 | BTK | 0.50070606 |
| 118 | OBSCN | 0.48797999 |
| 119 | KIT | 0.48624639 |
| 120 | EIF2AK3 | 0.48443881 |
| 121 | CSNK2A2 | 0.45894706 |
| 122 | TESK1 | 0.45744238 |
| 123 | ILK | 0.45507955 |
| 124 | EIF2AK2 | 0.44305610 |
| 125 | AURKA | 0.44296797 |
| 126 | CSNK1G3 | 0.43839176 |
| 127 | CDK11A | 0.43498082 |
| 128 | CHUK | 0.41962713 |
| 129 | PDK2 | 0.41631782 |
| 130 | PDK3 | 0.41209084 |
| 131 | PDK4 | 0.41209084 |
| 132 | CDK15 | 0.40981449 |
| 133 | MAPK15 | 0.40679316 |
| 134 | ZAK | 0.39816355 |
| 135 | CDK14 | 0.39107183 |
| 136 | BMX | 0.37791850 |
| 137 | CSNK2A1 | 0.37397119 |
| 138 | MAP3K7 | 0.37376511 |
| 139 | CDK18 | 0.36315555 |
| 140 | ITK | 0.36252884 |
| 141 | CLK1 | 0.35914314 |
| 142 | CSNK1G1 | 0.35687013 |
| 143 | DDR2 | 0.34991455 |
| 144 | EPHA3 | 0.34192336 |
| 145 | FGFR1 | 0.33547058 |
| 146 | RPS6KA6 | 0.31951104 |
| 147 | AKT2 | 0.30980587 |
| 148 | MAPK4 | 0.30713209 |
| 149 | ERBB2 | 0.30554818 |
| 150 | RPS6KC1 | 0.29297889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.82031902 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.15489033 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.13558668 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.69128556 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.63946595 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.52815532 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.45944844 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.42971318 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.33329847 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.30188844 |
| 11 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.24474372 |
| 12 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.24228936 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.10946325 |
| 14 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.10702512 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.05828754 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.02811262 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.01685359 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.87558602 |
| 19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.77824595 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.74850572 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.70174886 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.67567738 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.66169020 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.65474368 |
| 25 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61120369 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.58010649 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.57048090 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55486496 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.52192938 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.51711814 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51132601 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.49796042 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.48465445 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.46996233 |
| 35 | Carbon metabolism_Homo sapiens_hsa01200 | 1.46710538 |
| 36 | RNA polymerase_Homo sapiens_hsa03020 | 1.45923463 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.45057189 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.45006004 |
| 39 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.44310051 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.41481100 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.39638173 |
| 42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.39613437 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35393957 |
| 44 | Sulfur relay system_Homo sapiens_hsa04122 | 1.35327027 |
| 45 | DNA replication_Homo sapiens_hsa03030 | 1.31731270 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.27543777 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23165472 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20695712 |
| 49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.13567024 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 1.08176652 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.02549341 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02230640 |
| 53 | Lysine degradation_Homo sapiens_hsa00310 | 1.01143139 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 0.96650356 |
| 55 | Purine metabolism_Homo sapiens_hsa00230 | 0.95832174 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95548697 |
| 57 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.95231103 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95122904 |
| 59 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.94047734 |
| 60 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.93937564 |
| 61 | Mismatch repair_Homo sapiens_hsa03430 | 0.91768578 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.91191887 |
| 63 | Thyroid cancer_Homo sapiens_hsa05216 | 0.89981788 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84883825 |
| 65 | Parkinsons disease_Homo sapiens_hsa05012 | 0.83706374 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82806885 |
| 67 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.82122302 |
| 68 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73811161 |
| 69 | Huntingtons disease_Homo sapiens_hsa05016 | 0.71512665 |
| 70 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67102967 |
| 71 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.66594726 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66287658 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66039583 |
| 74 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.62797136 |
| 75 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.57629910 |
| 76 | Base excision repair_Homo sapiens_hsa03410 | 0.55134212 |
| 77 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.54686346 |
| 78 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.54397438 |
| 79 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.53624324 |
| 80 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.52662449 |
| 81 | Adherens junction_Homo sapiens_hsa04520 | 0.51499411 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.48812982 |
| 83 | RNA degradation_Homo sapiens_hsa03018 | 0.48143486 |
| 84 | Alzheimers disease_Homo sapiens_hsa05010 | 0.47319583 |
| 85 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.46727833 |
| 86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.46672118 |
| 87 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.44612297 |
| 88 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44077035 |
| 89 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.42392549 |
| 90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41662746 |
| 91 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.41561488 |
| 92 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.39773611 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39648194 |
| 94 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.38842370 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.37419665 |
| 96 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.37209067 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.37027873 |
| 98 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.36668003 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35588653 |
| 100 | Basal transcription factors_Homo sapiens_hsa03022 | 0.34583813 |
| 101 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.34216377 |
| 102 | Ribosome_Homo sapiens_hsa03010 | 0.33500800 |
| 103 | Proteasome_Homo sapiens_hsa03050 | 0.33319001 |
| 104 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.31539669 |
| 105 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.30190027 |
| 106 | Bladder cancer_Homo sapiens_hsa05219 | 0.30049521 |
| 107 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.29821757 |
| 108 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29728094 |
| 109 | RNA transport_Homo sapiens_hsa03013 | 0.28171333 |
| 110 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.28155347 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.25443047 |
| 112 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25221343 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24980065 |
| 114 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.24457478 |
| 115 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.22903393 |
| 116 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.22111705 |
| 117 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.21662487 |
| 118 | HTLV-I infection_Homo sapiens_hsa05166 | 0.21563349 |
| 119 | Legionellosis_Homo sapiens_hsa05134 | 0.21141074 |
| 120 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.15939073 |
| 121 | Spliceosome_Homo sapiens_hsa03040 | 0.14706581 |
| 122 | Homologous recombination_Homo sapiens_hsa03440 | 0.12455496 |
| 123 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.11151633 |
| 124 | Cell cycle_Homo sapiens_hsa04110 | 0.09914156 |
| 125 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.08304755 |
| 126 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.08095983 |
| 127 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.07540231 |
| 128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.07465696 |
| 129 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.06276542 |
| 130 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05083783 |
| 131 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.04692602 |

